Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.

Kroken RA, Johnsen E, Alisauskiene R, Anda LG, Bartz-Johannesen C, Berle JØ, Bjarke J, Bruserud Ø, Fathian F, Fleischhacker WW, Hugdahl K, Joa I, Kjelby E, Larsen TK, Løberg EM, Ratke I, Rettenbacher M, Sinkeviciute I, Skrede S, Stabell L, Steen VM, Torsvik A, Reitan SK.

Open source

DOI: 10.1016/j.psychres.2026.117266
Published: 2026-06-10
Container: Psychiatry Res
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.psychres.2026.117266,
  title = {Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.},
  author = {Kroken RA and  Johnsen E and  Alisauskiene R and  Anda LG and  Bartz-Johannesen C and  Berle JØ and  Bjarke J and  Bruserud Ø and  Fathian F and  Fleischhacker WW and  Hugdahl K and  Joa I and  Kjelby E and  Larsen TK and  Løberg EM and  Ratke I and  Rettenbacher M and  Sinkeviciute I and  Skrede S and  Stabell L and  Steen VM and  Torsvik A and  Reitan SK.},
  year = {2026},
  journal = {Psychiatry Res},
  doi = {10.1016/j.psychres.2026.117266},
  url = {https://doi.org/10.1016/j.psychres.2026.117266}
}

RIS

TY  - JOUR
TI  - Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
AU  - Kroken RA
AU  -  Johnsen E
AU  -  Alisauskiene R
AU  -  Anda LG
AU  -  Bartz-Johannesen C
AU  -  Berle JØ
AU  -  Bjarke J
AU  -  Bruserud Ø
AU  -  Fathian F
AU  -  Fleischhacker WW
AU  -  Hugdahl K
AU  -  Joa I
AU  -  Kjelby E
AU  -  Larsen TK
AU  -  Løberg EM
AU  -  Ratke I
AU  -  Rettenbacher M
AU  -  Sinkeviciute I
AU  -  Skrede S
AU  -  Stabell L
AU  -  Steen VM
AU  -  Torsvik A
AU  -  Reitan SK.
PY  - 2026
JO  - Psychiatry Res
DO  - 10.1016/j.psychres.2026.117266
UR  - https://doi.org/10.1016/j.psychres.2026.117266
ER  -

APA

RA, K., E, J., R, A., LG, A., C, B., JØ, B., J, B., Ø, B., F, F., WW, F., K, H., I, J., E, K., TK, L., EM, L., I, R., M, R., I, S., S, S., L, S., VM, S., A, T., & SK., R. (2026). Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.. Psychiatry Res. https://doi.org/10.1016/j.psychres.2026.117266

Source records

europe-pmc · retrieved 2026-09-26T01:26:51.885Z